Tag: PayPal

PayPal
Financial Technology
USA

Valuation Analysis: PayPal

PayPal combines a comparatively low valuation with rising payment volumes and strong cash flow; however, growth and margins remain key
Continue Umbrella
PayPal
Financial Technology
USA

Stock: PayPal

PayPal was moved to the UMBRELLA Watchlist. Following the confirmed breach of the stop-loss, the remaining position was sold in
Continue Umbrella
Weekly Update

Weekly Market Overview – August 3-August 9, 2026

Palantir impresses with strong growth. The UMBRELLA strategy also focuses on healthcare, European defense, and structural trends.
Continue Umbrella
Weekly Update

Weekly Market Overview – August 24–August 30, 2026

Revolution Medicines reaches a major milestone with the FDA approval of RASONQUE, while PayPal saw significant price fluctuations following the
Continue Umbrella
PayPal
Company Update

PayPal: Stop-Loss Triggers Complete Exit

PayPal falls below the stop-loss. The UMBRELLA Strategy sells the position in full and moves the stock to the watchlist.
Continue Umbrella
PayPal
Company Update

PayPal Update: Is the stock stabilizing after the sell-off?

PayPal is recovering after the sell-off. The chart, analyst consensus, and fundamental development show initial signs of stabilization.
Continue Umbrella
MUMAK SpotLight

MUMAK SpotLight of the week: Revolution Medicines with FDA breakthrough. PayPal and Palantir in focus

Revolution Medicines reaches a decisive milestone with the FDA approval of Daraxonrasib. PayPal loses a key short-term price driver as
Continue Umbrella